Ушбу иш иқтибос қилган ишлар

229 та иш

Иш: Mechanistic insights and emerging applications of human metapneumovirus (HMPV) treatment: From molecular design to translational immunity

A CRISPR/Cas12a-empowered surface plasmon resonance platform for rapid and specific diagnosis of the Omicron variant of SARS-CoV-2
Zhi Chen, Jingfeng Li, Tianzhong Li +20
Мақола20225 иқтибос
ABI
Development of a candidate mRNA vaccine based on Multi-Peptide targeting VP4 of rotavirus A: an immunoinformatics and molecular dynamics approach
Cena Aram, Leila Karami, Mohammad Mehdi Ranjbar
Мақола20255 иқтибос
ABI
An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
Hanqi Zhang, Buzi Cao, Qingtai Cao +3
Шарҳ мақола20234 иқтибос
ABI
Exploration of the protein and pharmacological landscape of monkeypox virus treatment: from entry point to end point
Cena Aram, Maryam Barancheshmeh, Ali Alishvandi +6
Мақола20254 иқтибос
ABI
The HER2 target for designing novel multi-peptide vaccine against breast cancer using immunoinformatics and molecular dynamic simulation
Faezeh Firuzpour, Maryam Barancheshmeh, Fariba Fallah Ziarani +2
Мақола20253 иқтибос
ABI
SIRT6 Protects Against Lipopolysaccharide-Induced Inflammation in Human Pulmonary Lung Microvascular Endothelial Cells
Jinping Wang, Jinque Luo, Dante Rotili +4
Мақола20233 иқтибос
ABI
Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies
Yilai Jia, Boyang Fu, Liping Dong +1
Шарҳ мақола20233 иқтибос
ABI
Urinary exosomes: Emerging biomarkers for urinary tract infection
Narbaev Zafar, Umurzoqov Dilmurod, Islom Kadirov +10
МақолаExtracellular vesicles in diseaseClinica Chimica Acta20252 иқтибос
ABI
Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms
Bushra Faryal, Zain Ul Abideen, Muhammad Irfan +4
МақолаProtein Degradation and InhibitorsBiomolecules20262 иқтибос
ABI
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
Ashley V. Menk, Nicole E. Scharping, Dayana B. Rivadeneira +5
Мақола20182 иқтибос
ABI
Artificial intelligence for modelling infectious disease epidemics
Moritz U. G. Kraemer, Joseph L.-H. Tsui, Serina Chang +38
Шарҳ мақола20252 иқтибос
ABI
A signal enhanced lateral flow immunoassay based on core–shell quantum dots labeled antibody and antigen for sensitive detection of CP4-EPSPS protein
Haijuan Zeng, Yan Zhang, Minghao Zhang +5
Мақола20252 иқтибос
ABI
Viral expression of NE/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory/effector CD8+ T cell infiltration
Shuo Wang, Lingkai Kong, Linpei Wang +7
Мақола20252 иқтибос
ABI
In silico design of a multi-epitope vaccine against NSCLC targeting T-cell exhaustion and metastasis: insights from RNA-seq and molecular dynamics simulation analysis
Ali Alishvandi, Cena Aram, Maryam Barancheshemeh +3
Мақола20262 иқтибос
ABI
The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials
Lang Wu, Jasur Rizaev, Khaled Fahmi Fawy +7
МақолаCAR-T cell therapy researchClinical & Translational Oncology20261 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI